EUCTR2012-005628-13-IT进行中(未招募)1 期
Transplantation of Human Fetal Liver Cells for the Treatment of Patients with Decompensated Liver Cirrhosis - HFLTX
ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE0 个研究点目标入组 40 人开始时间: 2013年1月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •a) Clinical diagnosis (evidence of chronic liver disease, presence of ascites and/or esophageal varices upon upper digestive endoscopy and/or ultrasound evidence of portal hypertension) or histological diagnosis of liver cirrhosis of any etiology. b) Liver failure documented by a score = B8 based on the Child-Pugh classification, and MELD score = 15. c) Informed consent to the study signed by the patient.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •MELD score > 28 • Hepatocellular carcinoma (HCC) • Portal vein thrombosis • Serious cardiovascular or respiratory disease, or other medical condition which may threaten patient’s life in the subsequent three months • Admission to the intensive care unit (ICU) • Hemodynamic instability (MAP < 55 mmHg) • Use of vasoactive drugs (e.g., epinephrine, norepinephrine, vasopressin, dopamine, terlipressine) • Type-1 (acute) hepatorenal syndrome • Levels of serum creatinine >2 mg/dl and/or creatinine clearance <30-40 ml/min • Sepsis, active infection or spontaneous bacterial peritonitis • Gastrointestinal bleeding or recent gastrointestinal bleeding episode (in the previous 4 weeks) • Consumption of alcohol • Serious alcoholic hepatitis • Pulmonary hypertension (PAP > 35 mmHg) • History of neoplasia • Pregnancy • Non-Sicilian residency • HBV DNA positive • HIV infection • Drug addiction • Age < 18 years • Partecipation in concomitant studies • Transjugular intrahepatic portosystemic shunt (TIPS) placed in the previous three months • Contraindications to the procedure (i.e., related to the splenic artery: aneurysm, kinking, thrombosis, thrombosis; related to the spleen: large angioma).
研究者
相似试验
已完成
1 期
Human Fetal Liver Cell Transplantation in Chronic Liver FailureLiver CirrhosisNCT01013194The Mediterranean Institute for Transplantation and Advanced Specialized Therapies25
招募中
不适用
iving-donor liver transplantation for unresectable perihilar cholangiocarcinomaperihilar cholangiocarcinomaJPRN-UMIN000033348Kyoto University10
招募中
1 期
iving donor liver transplantation for unresectable perihilar cholangiocarcinomaPerihilar cholangiocarcinomaJPRN-jRCT1070220052Hibi Taizo20
招募中
Unknown
iving donor liver transplantation for non-resectable colorectal liver metastasesnon-resectable colorectal liver metastasesJPRN-UMIN000049785Kyoto University23
尚未招募
1 期
iving donor liver transplantation for non-resectable colorectal liver metastasesnon-resectable colorectal liver metastasesnon-resectable colorectal liver metastases, Living donor liver transplantationJPRN-jRCT1050230053Hatano Etsuro23
